跳至主要内容
临床试验/NCT02225197
NCT02225197已完成不适用

A Phase II Study of Fractionated CyberKnife Stereotactic Radiosurgery to Perioptic Tumors

Community Cancer Center, Normal, Illinois1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2007年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
10
试验地点
1
主要终点
Tumor status

研究概览

简要总结

The purpose of this study is to find out what effects (good and bad) CyberKnife stereotactic radiosurgery has on tumors near the critical structures of the eye (optic apparatus).

The investigators hypothesize that hypofractionated stereotactic radiotherapy via the CyberKnife ® can deliver tumor ablating doses of radiation to perioptic lesions safely and effectively while sparing the adjacent optic apparatus and normal brain tissues from receiving damaging doses of radiation.

详细描述

The CyberKnife system is a type of radiation machine that uses a special system to precisely focus large doses of x-rays (radiation) on the tumor. The device is designed to concentrate large doses of radiation onto the tumor so that injury from radiation to the nearby normal tissue will be minimal.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Perioptic lesion within 2mm of the optic apparatus
  • •Age >= 21
  • •KPS >= 50
  • •Planning Target Volume (PTV) <= 6.0 cm in maximal diameter

排除标准

  • •Malignant histology
  • •Age < 21
  • •KPS <= 40
  • •Planning Target Volume (PTV) > 6.0 cm in maximal diameter
  • •Prior whole brain XRT
  • •Gross total resection

研究组 & 干预措施

CyberKnife Radiosurgery

Experimental

干预措施: CyberKnife Radiosurgery (Radiation)

结局指标

主要结局

Tumor status

时间窗: 5 years

To determine the local control rate of patients with perioptic lesions treated with stereotactic CyberKnife radiosurgery.

次要结局

未报告次要终点

研究者

发起方
Community Cancer Center, Normal, Illinois
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验